Charles Schwab’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$922K Buy
75,171
+2,866
+4% +$35.2K ﹤0.01% 2923
2025
Q1
$796K Buy
+72,305
New +$796K ﹤0.01% 2921